Skip to main content

Regeneron Pharmaceuticals, Inc 10-Q for FY2026 Q1

Regeneron Pharmaceuticals, Inc. (REGN)

10-Q 2026-04-29 For: 2026-03-31
View Original
Added on April 29, 2026

About this 10-Q

Regeneron Pharmaceuticals, Inc filed this 10-Q on April 29, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).

Headline figures

Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$3.61B
up 19.0% from $3.03B a year earlier
Net income
$727.2M
down 10.1% from net income of $808.7M a year earlier
Diluted EPS
$6.75
down 7.2% from $7.27 a year earlier